Generic placeholder image



ISSN (Print): 2666-7967
ISSN (Online): 2666-7975

Short Communication

Amantadine Might be Used as a Drug for SARS-Cov-2 Treatment?

Author(s): Zeynep Gunes Ozunal and Sevki Sahin*

Volume 2, Issue 1, 2021

Published on: 13 July, 2020

Page: [6 - 7] Pages: 2

DOI: 10.2174/2666796701999200713192912


Coronavirus Disease 2019 (COVID-19) infection, the pandemics, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has no known effective radical pharmacotherapy and just supportive approach at present. Amantadine is a drug used in Parkinson’s disease and other parkinsonisms; and is known to increase indirectly dopamine by antagonistic effects at the N-methyl-Daspartate (NMDA) receptor by increasing the release and blocking the reuptake of dopamine. Initially, amantadine was approved as an antiviral drug. We hypothesize that if amantadine is considered its antiviral, immunological and neurostimulant effects might be useful in the supportive treatment of SARSCoV- 2 cases, especially those who developed acute respiratory failure with decreased vigilance and are being monitored in the intensive care unit. Further phase III clinical trials are needed.

Keywords: Amantadine, pharmacology, neurology, SARS-CoV-2, drug repositioning, COVID-19.

© 2024 Bentham Science Publishers | Privacy Policy